Platelet Rich Plasma (PRP) Therapy in Newark, NJ

What I’d check before adding platelet rich plasma therapy here

Adult obesity in Newark is 35.9% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. CDC PLACES (2023, crude) estimates 14.6% of adults in Newark have diagnosed diabetes — 2.6 points above the U.S. 12% figure. New Jersey is outside CDC’s core Diabetes Belt list; use the PLACES city rate anyway. Hawk Medical is the distributor for platelet rich plasma therapy, not a walk-in clinic.

Cash PRP and Medicare CTPs in the same hallway

• CDC PLACES (2023, crude) estimates 14.6% of adults in Newark have diagnosed diabetes — 2.6 points above the U.S. 12% figure. Adult arthritis here is 19.9% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Separate 361 tissue, PRP, and CTP tickets before you market platelet rich plasma therapy in Newark. Mixing lanes is how recoupments start.
• PRP is autologous and not an HCT/P 361 allograft, but payers in JL still expect diagnosis-driven documentation. A 1-minute spin does not replace a medically necessary indication or a procedure note.
• Orthopedic and wound-care buyers in New Jersey are often different people inside the same health system. A single Hawk Medical account can still require two utilization policies so 361 tissue and CTPs are not interchanged.

Uninsured mix and Medicare CTPs in the same building

JL reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Newark is 14.6% or not. PLACES is planning data. The LCD is the claim.

Before the first platelet rich plasma therapy shipment